An official website of the United States government
Home
This neoplasm is not reportable.
Name
Lymphoproliferative disorder, NOS
ICD-O-3 Morphology
9970/1: Chronic lymphoproliferative disorder
Effective
2001 and later
Reportability
This neoplasm is not reportable
Primary Site(s)
No primary site specified
This hematopoietic disease is not reportable for the U.S. except for primary sites C700-C729, C751-C753.
Canada, refer to your specific province for reportability requirements.
Canada, refer to your specific province for reportability requirements.
Abstractor Notes
Lymphoproliferative disorder, NOS is not included in the WHO 5th edition of Hematolymphoid Tumors. (See Appendix B in the Hematopoietic Manual, Table B23)
Alternate Names
Lymphoproliferative disease, NOS
Definition
Lymphoproliferative disorders (LPD) refer to several conditions in which lymphocytes are produced in excessive quantities. They are characterized by the abnormal proliferation of lymphocytes into a monoclonal lymphocytosis. Individuals who have some sort of immunodysfunction are susceptible to developing LPD.
Corresponding ICD-10 Codes (Cause of Death codes only)
D47.9 Neoplasm of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue, unspecified
Corresponding ICD-10-CM Codes (U.S. only)
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (effective October 01, 2015)
Sources
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2011, 2011, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
